Dataset Information


Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases.

ABSTRACT: Clinical response to methotrexate (MTX) treatment for children with juvenile idiopathic arthritis (JIA) displays considerable heterogeneity. Currently, there are no reliable predictors to identify non-responders: earlier identification could lead to a targeted treatment. We genotyped 759 JIA cases from the UK, the Netherlands and Czech Republic. Clinical variables were measured at baseline and 6 months after start of the treatment. In Phase I analysis, samples were analysed for the association with MTX response using ordinal regression of ACR-pedi categories and linear regression of change in clinical variables, and identified 31 genetic regions (P<0.001). Phase II analysis increased SNP density in the most strongly associated regions, identifying 14 regions (P<1 × 10(-5)): three contain genes of particular biological interest (ZMIZ1, TGIF1 and CFTR). These data suggest a role for novel pathways in MTX response and further investigations within associated regions will help to reach our goal of predicting response to MTX in JIA.


PROVIDER: S-EPMC4091986 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6791251 | BioStudies
2016-01-01 | S-EPMC4902726 | BioStudies
2011-01-01 | S-EPMC3128324 | BioStudies
1000-01-01 | S-EPMC5850489 | BioStudies
2019-01-01 | S-EPMC6858017 | BioStudies
2015-01-01 | S-EPMC4349799 | BioStudies
2019-01-01 | S-EPMC6622540 | BioStudies
2016-01-01 | S-EPMC4847326 | BioStudies
2010-01-01 | S-EPMC2963015 | BioStudies
2017-05-10 | GSE81259 | GEO